company background image
1784 logo

BIONET TPEX:1784 Stock Report

Last Price

NT$80.00

Market Cap

NT$4.1b

7D

-4.1%

1Y

47.5%

Updated

24 Dec, 2024

Data

Company Financials

1784 Stock Overview

Provides cord blood banking services in Taiwan and internationally. More details

1784 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

BIONET Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for BIONET
Historical stock prices
Current Share PriceNT$80.00
52 Week HighNT$162.01
52 Week LowNT$52.76
Beta0.76
1 Month Change-13.79%
3 Month Change-18.03%
1 Year Change47.46%
3 Year Change117.45%
5 Year Change111.28%
Change since IPO503.39%

Recent News & Updates

Recent updates

Should You Investigate BIONET Corp. (GTSM:1784) At NT$43.50?

Apr 10
Should You Investigate BIONET Corp. (GTSM:1784) At NT$43.50?

If You Had Bought BIONET (GTSM:1784) Shares Three Years Ago You'd Have Earned 46% Returns

Feb 10
If You Had Bought BIONET (GTSM:1784) Shares Three Years Ago You'd Have Earned 46% Returns

Shareholder Returns

1784TW HealthcareTW Market
7D-4.1%-0.4%0.4%
1Y47.5%-10.8%28.7%

Return vs Industry: 1784 exceeded the TW Healthcare industry which returned -10.8% over the past year.

Return vs Market: 1784 exceeded the TW Market which returned 28.7% over the past year.

Price Volatility

Is 1784's price volatile compared to industry and market?
1784 volatility
1784 Average Weekly Movement6.3%
Healthcare Industry Average Movement3.6%
Market Average Movement4.4%
10% most volatile stocks in TW Market7.8%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 1784's share price has been volatile over the past 3 months compared to the TW market.

Volatility Over Time: 1784's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of TW stocks.

About the Company

FoundedEmployeesCEOWebsite
1989n/an/awww.bionetcorp.com

BIONET Corp. provides cord blood banking services in Taiwan and internationally. The company offers stem cell banking services, including stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC + immune cells; and genetic testing services. It also provides stem anti-aging and ANIKINE series products.

BIONET Corp. Fundamentals Summary

How do BIONET's earnings and revenue compare to its market cap?
1784 fundamental statistics
Market capNT$4.06b
Earnings (TTM)NT$55.72m
Revenue (TTM)NT$1.18b

72.8x

P/E Ratio

3.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1784 income statement (TTM)
RevenueNT$1.18b
Cost of RevenueNT$529.73m
Gross ProfitNT$648.00m
Other ExpensesNT$592.27m
EarningsNT$55.72m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.10
Gross Margin55.02%
Net Profit Margin4.73%
Debt/Equity Ratio3.0%

How did 1784 perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

60%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 00:01
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BIONET Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xiaowei HuangMasterlink Securities Corp.